ESMO Guidance for Reporting Oncology real-World evidence (GROW)
European Society for Medical Oncology · Université Paris Cité · +34 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
201
total citations
- FWCI
- 112.26
- Percentile
- 100%
- References
- 68
Citations per year
Authors
23- LCLuís Castelo-BrancoCorresponding
European Society for Medical Oncology
- APAnna Pellat
Université Paris Cité, Hôpital Cochin, Assistance Publique – Hôpitaux de Paris, Hôtel-Dieu de Paris
- DMDiogo Martins-Branco
Université Libre de Bruxelles, European Society for Medical Oncology, Institut Jules Bordet
- AVAntonios Valachis
Örebro University Hospital
- JWJeroen W. G. Derksen
Utrecht University, University Medical Center Utrecht
Topics & keywords
Topics
Keywords
- Medicine
- Real world evidence
- Multidisciplinary approach
- Expert opinion
- Oncology
- Medical education
- Internal medicine
- Intensive care medicine
UN Sustainable Development Goals
- Partnerships for the goals
No related works found for this paper.
Funding
- AAmgen
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- SSanofi
- GSGilead Sciences
- AIAssociazione Italiana di Oncologia Medica
- LLLes Laboratories Pierre Fabre
- COClovis Oncology
- IIncyte
- PBPuma Biotechnology
- SSeagen
- ECEuropean Commission
- EEisai
- APAstellas Pharma
- ESEuropean Society for Medical Oncology
- SServier
- IIpsen
- NPNordic Pharma Group
- SMSirtex Medical
- GGenentech
- FMFoundation Medicine
- CCilag